AIRDF (Rocket Doctor AI) EBIT: $-13.14 Mil (TTM As of Mar. 2026)


AIRDF Rocket Doctor AI Inc AIRDF
29 GF Score
Price $0.44
! 7 Warning Signs
View Full Analysis

What is Rocket Doctor AI EBIT?

Rocket Doctor AI AIRDF +0.50% 29 EBIT is $-13.14 Mil as of Mar. 2026. GuruFocus rates AIRDF with a GF Score™ of 29/100. The stock has 7 warning signs investors should review.

Rocket Doctor AI's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-3.37 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-13.14 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Rocket Doctor AI's annualized ROC % for the quarter that ended in Mar. 2026 was -174.31%. Rocket Doctor AI's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -89,786.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Rocket Doctor AI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -32.41%.

Rocket Doctor AI  (OTCPK:AIRDF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Rocket Doctor AI's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-12.76 * ( 1 - 0% )/( (7.276 + 7.365)/ 2 )
=-12.76/7.3205
=-174.31 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7.713 - 1.409 - ( 0.465 - max(0, 1.661 - 0.689+0.465))
=7.276

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9.765 - 1.313 - ( 2.548 - max(0, 1.657 - 2.744+2.548))
=7.365

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Rocket Doctor AI's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-13.468/( ( (0.008 + max(-1.287, 0)) + (0.022 + max(-1.228, 0)) )/ 2 )
=-13.468/( ( 0.008 + 0.022 )/ 2 )
=-13.468/0.015
=-89,786.67 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.059 + 0 + 0.165) - (1.409 + 0.034 + 0.068)
=-1.287

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.103 + 0 + 0.093) - (1.313 + 0.042 + 0.069)
=-1.228

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Rocket Doctor AI's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-13.139/40.543
=-32.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rocket Doctor AI EBIT Related Terms

Rocket Doctor AI EBIT Historical Data

* Premium members only.

The historical data trend for Rocket Doctor AI's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rocket Doctor AI EBIT Chart

Rocket Doctor AI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -10.83 -2.76 -2.72 -5.28 -11.31

Rocket Doctor AI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.49 -1.96 -2.53 -5.29 -3.37

AIRDF vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, Rocket Doctor AI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rocket Doctor AI EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Rocket Doctor AI's EV-to-EBIT falls into.


AIRDF
29GF Score
Rocket Doctor AI Inc AIRDF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rocket Doctor AI EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-13.14 Mil mean?
Rocket Doctor AI (AIRDF) has a EBIT of $-13.14 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Rocket Doctor AI.
Is Rocket Doctor AI's EBIT too high?
Rocket Doctor AI's current EBIT is $-13.14 Mil. Overall, Rocket Doctor AI has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's EBIT compare to VEEV and BTSG?
Rocket Doctor AI's EBIT of $-13.14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Rocket Doctor AI. Rocket Doctor AI's current EBIT is $-13.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current EBIT of $-13.14 Mil. The current EBIT is $-13.14 Mil. Rocket Doctor AI's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current EBIT is $-13.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rocket Doctor AI Business Description

Other Exchanges 9390:GermanyAIDR:Canada
Address 700-838 W Hastings Street, Vancouver, BC, CAN, V6C 0A6
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
29GF Score

Get the complete analysis for AIRDF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price